Sort by
Refine Your Search
-
Category
-
Country
-
Employer
- University of Cambridge;
- Autonomous University of Madrid (Universidad Autónoma de Madrid)
- Fundacio de Recerca Clinic Barcelona-Institut d'Investigacions Biomediques August Pi i Sunyer
- German Cancer Research Center in the Helmholtz Association (DKFZ)
- Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
- IBIMA Plataforma BIONAND
- Johannes Gutenberg University Mainz •
- Purdue University
- SciLifeLab
- The Ohio State University
- The University of Chicago
- University of Basel
- University of Birmingham
- University of Gdansk
- University of Mainz
- Université Paris Cité
- 6 more »
- « less
-
Field
-
immunotherapy, cell therapy, and translational pediatric oncology. · Prior hands-on experience with cell culture, flow cytometry, molecular biology techniques, and/or handling of laboratory animals will be
-
multimodal algorithm of epigenetic blood predictors of the clinical benefit of SBRT in immunotherapy-resistant tumors Research Line: IBIMA-BE-17 CLINICAL, MOLECULAR, AND TECHNOLOGICAL RESEARCH IN RADIATION
-
) at Uppsala University and SciLifeLab , the national infrastructure for life science. Project description Immunotherapy has become a life-saving option for advanced cancer patients. However, only a minority of
-
immunotherapy. Possible project elements include: Artificial cells that process cytokine signals or re-establish tissue homeostasis Synthetic signaling hubs for tumor-microenvironment models Reporter cell assays
-
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt | Germany | 3 months ago
drive metabolic disorders and to translate these insights into precise, context-specific immunotherapies. Ultimately, we strive to develop strategies that modulate immune responses while supporting tissue
-
/SPECT, CT, MRI, optical, etc.) therapeutic applications (radiotherapy, immunotherapy, phototherapy, etc.). Investigate mechanisms at the nano-bio interface to better modulate immune responses, the tumor
-
" with its three research areas "Immunotherapy", "Translational Neurosciences" and "Translational Vascular Biology". Beyond this, TransMed is the umbrella organisation for all training groups within